Showing results (41-50 of 163) with videos related to

Sort By:
Pageof 17
Cytotechnology|January 1, 1991
Alternative methods in toxicology tests: in vitro toxicityS Cinelli, A Falezza, C Meli, et al.
Blood and Lymphatic Cancer : Targets and Therapy|August 16, 2019
<i>IDH1</i>-mutated relapsed or refractory AML: current challenges and future prospectsJuan Eduardo Megías-Vericat, Octavio Ballesta-López, Eva Barragán, et al.
The Journal of Chemical Physics|August 22, 2008
Continuum percolation of long lifespan clusters in a simple fluidLuis A Pugnaloni, Carlos M Carlevaro, Marcos G Valluzzi, et al.
Interdisciplinary Sciences, Computational Life Sciences|December 20, 2011
Genetic algorithm for the pair distribution function of the electron gasFernando Vericat, César O Stoico, C Manuel Carlevaro, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|May 21, 2005
Percolation of clusters with a residence time in the bond definition: Integral equation theoryGuillermo J Zarragoicoechea, Luis A Pugnaloni, Fred Lado, et al.
Nanotechnology|February 24, 2023
Redox phase transformations in magnetite nanoparticles: impact on their composition, structure and biomedical applicationsGabriel C Lavorato, Adriele A de Almeida, Carolina Vericat, et al.
BMJ Case Reports|October 14, 2020
Clinical, pharmacokinetic and economic analysis of the first switch to an extended half-life factor IX (albutrepenonacog alfa, rFIX-FP) in SpainManuel Rodríguez López, Juan Eduardo Megías Vericat, Carmen Albo López, et al.
Expert Review of Hematology|September 2, 2020
Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Antonio Solana-Altabella, et al.
Annals of Hematology|April 23, 2018
Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature reviewJuan Eduardo Megías-Vericat, David Martínez-Cuadrón, Miguel Ángel Sanz, et al.
Pageof 17